Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Akanda and Tetra-Bio

<< Previous

Bullboard Posts

Next >>

Comment by Davesnothereon Jan 01, 2023 2:05pm

160 Views

Post# 35199026

RE:RE:Akanda and Tetra-Bio

Or, at the very latest >>>> end of Feb 2023.

Final Answer !

Davesnothere wrote: Exactly !!! TBP is a sleeping giant. The share price today is meaningless except as a good chance to accumulate.

The real story has yet to unfold. We are not watching the share price.

We are waiting for news. It's closer now than ever, and that is beyond question...

Happy New Year

Free Prediction: REDUVO >>> DIN before Feb.1/23

EnoughBull wrote: The companies estimate the total addressable market (TAM) for QIXLEEF™ to be nearly $1.7 billion by 2028